Precision Biosensor Balance Sheet Health
Financial Health criteria checks 3/6
Precision Biosensor has a total shareholder equity of ₩31.4B and total debt of ₩15.2B, which brings its debt-to-equity ratio to 48.4%. Its total assets and total liabilities are ₩56.8B and ₩25.4B respectively.
Key information
48.4%
Debt to equity ratio
₩15.21b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩5.49b |
| Equity | ₩31.44b |
| Total liabilities | ₩25.36b |
| Total assets | ₩56.79b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: A335810's short term assets (₩16.7B) exceed its short term liabilities (₩5.1B).
Long Term Liabilities: A335810's short term assets (₩16.7B) do not cover its long term liabilities (₩20.2B).
Debt to Equity History and Analysis
Debt Level: A335810's net debt to equity ratio (30.9%) is considered satisfactory.
Reducing Debt: A335810's debt to equity ratio has reduced from 374.7% to 48.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A335810 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: A335810 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 14.9% each year